Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Schmidt

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
BMC Health Services Research|April 2, 2024
Workforce strategies during the first wave of the COVID-19 pandemic: a retrospective online survey at intensive care units in GermanyLara C Stroth, Franziska Jahns, Berit Bode, et al.
Frontiers in Medicine|October 24, 2022
Safety management in times of crisis: Lessons learned from a nationwide status-analysis on German intensive care units during the COVID-19 pandemicMichelle Schmidt, Sophie Isabelle Lambert, Martin Klasen, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 10, 2004
Radiolabeled RGD-DTPA-Tyr3-octreotate for receptor-targeted radionuclide therapyBert Bernard, Astrid Capello, Martin van Hagen, et al.
European Journal of Immunology|April 7, 2011
Conditional deletion of SLP-76 in mature T cells abrogates peripheral immune responsesGregory F Wu, Evann Corbo, Michelle Schmidt, et al.
Kentucky Nurse|September 1, 2005
Databits. Research for practice: complementary methods of pain controlChristina Carroll, Erin Colston, Wesley Conn, et al.
Journal of Pain and Symptom Management|March 19, 2022
Development of Entrustable Professional Activities for Specialist Hospice and Palliative Care PharmacistsKashelle Lockman, Maria F Lowry, Sandra DiScala, et al.
Journal of Medicinal Chemistry|December 15, 2015
Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of OsteoarthritisPeter G Ruminski, Mark Massa, Joseph Strohbach, et al.
Cancer Discovery|February 17, 2021
Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic LymphomaVinod A Pullarkat, Norman J Lacayo, Elias Jabbour, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Aminopyrazole Carboxamide Bruton's Tyrosine Kinase Inhibitors. Irreversible to Reversible Covalent Reactive Group TuningMark E Schnute, Stephen E Benoit, Ingrid P Buchler, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
BMC Health Services Research|April 2, 2024
Workforce strategies during the first wave of the COVID-19 pandemic: a retrospective online survey at intensive care units in GermanyLara C Stroth, Franziska Jahns, Berit Bode, et al.
Frontiers in Medicine|October 24, 2022
Safety management in times of crisis: Lessons learned from a nationwide status-analysis on German intensive care units during the COVID-19 pandemicMichelle Schmidt, Sophie Isabelle Lambert, Martin Klasen, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 10, 2004
Radiolabeled RGD-DTPA-Tyr3-octreotate for receptor-targeted radionuclide therapyBert Bernard, Astrid Capello, Martin van Hagen, et al.
European Journal of Immunology|April 7, 2011
Conditional deletion of SLP-76 in mature T cells abrogates peripheral immune responsesGregory F Wu, Evann Corbo, Michelle Schmidt, et al.
Kentucky Nurse|September 1, 2005
Databits. Research for practice: complementary methods of pain controlChristina Carroll, Erin Colston, Wesley Conn, et al.
Journal of Pain and Symptom Management|March 19, 2022
Development of Entrustable Professional Activities for Specialist Hospice and Palliative Care PharmacistsKashelle Lockman, Maria F Lowry, Sandra DiScala, et al.
Journal of Medicinal Chemistry|December 15, 2015
Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of OsteoarthritisPeter G Ruminski, Mark Massa, Joseph Strohbach, et al.
Cancer Discovery|February 17, 2021
Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic LymphomaVinod A Pullarkat, Norman J Lacayo, Elias Jabbour, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Aminopyrazole Carboxamide Bruton's Tyrosine Kinase Inhibitors. Irreversible to Reversible Covalent Reactive Group TuningMark E Schnute, Stephen E Benoit, Ingrid P Buchler, et al.
Pageof 4